HIV Flashcards

1
Q

Lymphadenopathy Associated Virus (LAV)

A

Luc Montagnier at the Pasteur Institute in France

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

1983:

A

Luc Montagnier at the Pasteur Institute in France

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Human T Lymphotropic Virus Ill

A

Robert Gallo of US confirmed the discovery of the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1984

A

Robert Gallo of US confirmed the discovery of the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HUMAN IMMUNODEFICIENCY VIRUS (HIV)

A

President Mitterand of France and President Reagan of US resolved the issue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TWO TYPES OF HIV VIRUS

A

HIV-1

HIV-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

: HIV virus common worldwide

A

HIV-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

: HIV virus isolated in Africa

A

HIV-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3 Groups of HIV-1

A

Group M
Group N
Group O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

– major group

A

Group M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

– non m/non

A

Group N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

– outlier group

A

Group O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HIV Genus

A

Lentivirinae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HIV Family

A

Retroviridae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HIV Contains 2 positive single stranded RNA

A

SSrNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HIV Structure

[?] in diameter

A

100nm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

You can get HIV from:

A

 Sex without condom
 Passed from mother to baby (Vertical and perinatal)
 Sharing of equipment
 Contaminated transfusion transplants and blood organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

You cannot get HIV from:

A

 Kissing
 Hugging
 Sharing food
 Insect bites
 Toilet seats
 Bathing together
 Sneezes and cough
 Heat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HIV main MOT

A

Sex without condom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Target cell of HIV:

A

CD4 T cells (T helper cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Important Proteins

A

Gp41/Gp120 comples

p24

p17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

• Large glycoprotein that traverses the bilipid layer

A

Gp41/Gp120 comples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

• Gp120 and CD4 complex will interact with CCR5 and CXCR4 receptors of CD4 T cells p24

A

Gp41/Gp120 comples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

• Nucleocapsid core protein

A

p24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
One of the earliest marker to HIV infection
p24
26
The presence of [?] does not mean (+) for HIV
p24
27
• Matrix shell protein
p17
28
Important Enzymes
Reverse transcriptase Integrase Protease
29
• Enables the virus to convert viral RNA to DNA
Reverse transcriptase
30
• (Normal process: [?])
DNA to RNA
31
• Inserts viral DNA into host DNA
Integrase
32
Making it impossible to kill the virus; ability to persist in the host
Integrase
33
• Cleaves other enzymes and structural proteins from their polyproteins; important in formation of new virion
Protease
34
• Progressive deterioration of the immune system due to the destruction of CD4 cells
HIV INFECTION
35
Normal CD4:CD8 ratio =
2:1
36
CD4:CD8 ratio With HIV =
0.5:1
37
can occur in HIV INFECTION
Opportunistic infections
38
STAGES OF HIV INFECTION
Primary Stage Intermediate Stage Final Stage
39
Acute HIV
Primary Stage
40
Clinical Latency
Intermediate Stage
41
Opportunistic infections
Final Stage
42
• May be asymptomatic
Primary Stage
43
• Development of flu-like symptoms
Primary Stage
44
• Lymphadenopathy
Intermediate Stage
45
• Fever
Intermediate Stage
46
• Weight loss
Intermediate Stage
47
• Diarrhea
Intermediate Stage
48
• Fatigue, night sweats
Intermediate Stage
49
Intermediate Stage Labs:
T4 cells < 400/mm2 CD4:CD8 ratio is <1 (vs. normal ratio of 2:1) Thrombocytopenia, Leukopenia, Anemia
50
Aka HIV dormancy
Clinical Latency
51
Some may show s/s, while others may show little to none
Clinical Latency
52
Lasts 10 years or longer for some
Clinical Latency
53
rapid multiplication of the virus
Acute HIV
54
high viral load = high risk of transmission
Acute HIV
55
(inflamed/swollen lymph nodes)
Lymphadenopathy
56
Acquired Immune Deficiency Syndrome - AIDS (after 2-10 years)
Final Stage
57
Final Stage Labs:
T4 cells < 200/mm2
58
Opportunistic infections in Final Stage:
Pneumocystis jiroveci (formerly carinii) Candidiasis CMV Herpes simplex M. tb Kaposi’s sarcoma Hairy leukoplakia
59
(formerly carinii)
Pneumocystis jiroveci
60
HIV IMMUNOLOGIC FEATURES
1. Progressive depletion of T4 cells 2. Reversing the normal CD4:CD8 ratio (normal 2:1) to as low as 0.5:1 3. First detectable serologic marker is the core protein p24
61
HIV Screening tests
ELISA
62
HIV Confirmatory tests
Western blot assay
63
Solid phase assay
ELISA
64
>99.5% sensitivity
ELISA
65
Gold standard
Western blot assay
66
Most sensitive and specific for HIV-1
Western blot assay
67
Detects IgG Ab specific to HIV Ag (Ab against core protein p24)
Western blot assay
68
Positive results are bands on nitrocellulose membrane strip
Western blot assay
69
Why is antibody detection more commonly used?
1. Small size of pathogen especially HIV 2. Antibodies are widely distributed 3. Longer detection time of antibodies 4. Antibody testing is more practical
70
Assay Generations
1st Generation 2nd Generation 3rd Generation 4th Generation
71
• viral lysate
1st Generation
72
• recombinant disrupted virion
1st Generation
73
• use of biological vehicle
2nd Generation
74
• Synthetic peptide - mimics CHON
3rd Generation
75
• Peptide synthesizer
3rd Generation
76
• Recombinant Ag, Synthetic Peptide, and Monoclonal antibodies
4th Generation
77
1st Generation
western blot
78
2nd Generation
recombinant Ag - placed in fungi
79
3rd Generation
most of the test (test kits)
80
4th Generation
ELISA
81
"lateral flow" assay
Immunochromatography
82
Most widely used test for HIV screening
Immunochromatography
83
Easy to carry; used in outreaches; HIV tests in Session Road and lab exp in the lab
Immunochromatography
84
Advantages storage at room temperature, ease of use, and fast results, field testing
Immunochromatography
85
Disadvantages less sensitive and not recommended in blood banks
Immunochromatography
86
One of the first serological test developed for HIV
Enzyme-linked Immunosorbent assay (ELISA)
87
worldwide use
Enzyme-linked Immunosorbent assay (ELISA)
88
Advantages high sensitivity and specificity
Enzyme-linked Immunosorbent assay (ELISA)
89
Disadvantages false positives and machine maintenance; due to high sensitivity
Enzyme-linked Immunosorbent assay (ELISA)
90
Used by big hospitals and laboratories
Luminescence Assays
91
Relative light unit (luminometer)
Luminescence Assays
92
Advantages high sensitivity and specificity
Luminescence Assays
93
Disadvantages false positives, expensive maintenance issues
Luminescence Assays
94
Widely used in blood banks before
Agglutination
95
Results are difficult to distinguish; Need expertise
Agglutination
96
gelatin particles or RBC as carriers (TPHA)
Agglutination
97
Advantages differentiating test, high sensitivity and specificity
Agglutination
98
Disadvantages subjective reading, prozone phenomenon or Ab excess
Agglutination
99
obsolete test
Immunoconcentration Immunodot Assay
100
Aka "flow through" assay
Immunoconcentration
101
Same as Lateral flow or Immunochromatography
Immunoconcentration
102
Advantages storage at room temperature, ease of use, and fast results, field testing
Immunoconcentration
103
Synthetic test
Line Immunoassay
104
Disadvantages less sensitive, less specific, subjective reading
Immunoconcentration
105
Principle: Solid-phase ELISA
Immunodot Assay
106
Aka "dipstick" ELISA
Immunodot Assay
107
Same as Lateral flow but observation on dots instead of band or line
Immunodot Assay
108
Advantages highly specific, ease of use
Immunodot Assay
109
Disadvantages need ref for storage, subjective
Immunodot Assay
110
gold standard for HIV
Western blotting
111
Protein detection
Western blotting
112
Confirmatory test
Western blotting
113
Performed by the National Reference Laboratories
Western blotting
114
: followed to confirm truly (+) results
CDC/ASPHL criteria
115
Advantages very specific
Western blotting
116
Disadvantages tedious procedure, trained personnel
Western blotting
117
Requires electrophoresis after testing
Western blotting
118
According to these criteria, a result should be reported as positive if at least two of the following three bands are present:
o p24 o gp41 o gp120/gp160
119
A [?] test result is reported if either no bands are present.
negative
120
Specimens that have some of the characteristic bands present but do not meet the criteria for a positive test result are considered to be [?]
121
Neither positive nor negative; in between
indeterminate
122
Repeat result after 3 months
indeterminate
123
Only 1 of the bands mentioned in the criteria for (+) result is present
indeterminate
124
Ex. Not diagnostic if only p24 is present
indeterminate
125
Monitoring test (for effectiveness of treatment)
CD4 and Viral Load
126
To check for viral load
CD4 and Viral Load
127
Low/high count = ineffective treatment
CD4 and Viral Load
128
Hallmark feature of HIV: presence of reverse transcriptase and integrase
CD4 and Viral Load
129
Laser counting
CD4 count
130
FACS (fluorescence activated cell sorter)
CD4 count
131
Detects RNA/DNA ; HIV (RNA)
PCR/NAT/Viral load
132
Viral load (quanti)
PCR/NAT/Viral load
133
Qualitative or quantitative
PCR/NAT/Viral load
134
old name of HIV
Lymphadenopathy Associated Virus (LAV)
135
Common signs and symptoms: swollen lymph nodes
Lymphadenopathy Associated Virus (LAV)
136
Theories for HIV:
An individual made a sexual contact with a monkey Most accepted: due to Bush meat
137
Butchering different types of meat in Africa; Animal blood enters the body; High conc in blood, saliva, and sweat
Bush meat
138
Body fluids containing high viral load:
blood and sexual fluids (semen and vaginal)
139
vertical transmission or perinatal - Treatment:
Antiretroviral therapy
140
- Decreases viral load in the blood to prevent transmission
Antiretroviral therapy
141
Contaminated blood transfusion and organ transplants other viruses
Hepa B, Hepa C, HIV, Syphilis
142
1. HIV attaches to [?]
host CD4 cell
143
2. DNA is made from HIV’s RNA via [?]
reverse transcriptase
144
3. HIV DNA is [?] into host DNA (integrase)
integrated
145
4. Viral components are [?]
reproduced
146
5. HIV virus is [?]
assembled
147
6. HIV virus is [?]
distributed
148
1st thing to happen once infected with HIV
Progressive depletion of T4 cells
149
Ab rises during the [?] of infection (Ab test kits)
6th week
150
Ag is present as early as the [?] of infection (expensive machines)
0 week
151
CD4 T cells is high during the [?]; declines during the acute phase, but eventually rises with Ab as Ag declines
0 week
152
Normal RBC size: 7-8 micrometers; HIV is like a dot compared to RBC
Small size of pathogen especially HIV
153
Not only detected in serum but also in other body fluids
Antibodies are widely distributed
154
Once increased, there will be a constant production
Longer detection time of antibodies
155
Ag is expensive (PCR, NAT, RIBA; Ab is cheaper (rapid test kits)
Antibody testing is more practical
156
Ab-testing Principle:
Target and Capture
157
(reagent)
Capture analyte
158
Target and Capture:
Antigen (capture analyte) + Antibody (target analyte) = antigen-antibody complex
159
Western blotting HCV:
- Srip Immunoblot Assay (SIA) - Recombinant Immunoblot Assay(RIBA)
160
PRINCIPLE OF WESTERN BLOT Look for [?] 1st reagent: [?] Add [?] to stop the reaction Detection signal (?)
target protein Primary Antibody enzyme-conjugated secondary antibody and enzyme substrate colorimetric or chemiluminescent
161
Criteria for determining a positive test result have been published by the [?].(Stevens)
Association of State and Territorial Public Health Laboratory Directors and CDC, the Consortium for Retrovirus Serology Standardization, the American Red Cross, and the FDA